ArticleOncotarget2018
STK3 is a therapeutic target for a subset of acute myeloid leukemias.
Aylin Camgoz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleOncotarget2018
Aylin Camgoz et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.